Multiple sclerosis and disease-modifying therapiesAbout multiple sclerosis
Links shared publicly online about this topic.
- 104total visits
Multiple sclerosis and disease-modifying therapiesAbout multiple sclerosis
View full resource at neurology.org
Tags: Neurology, Multiple Sclerosis
Most Recently Shared on August 1, 2011 at 5:20 pm By:
Information for Patients! Multiple sclerosis and disease-modifying therapies / About multiple sclerosis http://bit.ly/owptTX #neurology
Higher Patient Adherence to Disease Modifying Therapies Reduced Costs for MS Patients
newswise.com — “Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients. This research was publis” View full resource at newswise.com
Most Recently Shared on November 28, 2011 at 6:27 pm By:
newswise Health News and Health Communicator
Higher Patient Adherence to Disease Modifying Therapies Reduced Costs for MS Patients: Avi Dor, Ph.D., professor... http://t.co/1MXxq9LA
When to Consider Changing Treatments - Disease-Modifying Drugs - Multiple Sclerosis
healthcentral.com — “As soon as you were diagnosed with multiple sclerosis, you had many decisions to make. One of those was whether to use a disease-modifying drug and, subsequently, which one to use.” View full resource at healthcentral.com
Most Recently Shared on November 21, 2011 at 3:25 pm By:
When to Consider Changing Treatments: As soon as you were diagnosed with multiple sclerosis, you had many decisi... http://t.co/Q5MBKB1b
Learn about Multiple Sclerosis
msfocus.org — “Learn about Multiple Sclerosis” View full resource at msfocus.org
Most Recently Shared on October 14, 2011 at 8:02 pm By:
Did you know? #inthe90s the first disease-modifying therapy, Betaseron became commercially available for #MS. http://t.co/228VPFN4
Abstract | Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study
biomedcentral.com — “Abstract | Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study” View full resource at biomedcentral.com
Most Recently Shared on October 6, 2011 at 7:22 pm By:
Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective ... http://t.co/5oo88vKo
Medical News: Health Gains May Not Justify Price of MS Drugs - in Clinical Context, Multiple Sclerosis from MedPage Today
medpagetoday.com — “Disease-modifying therapies (DMTs) in multiple sclerosis may offer clinical benefits, but they are far from being cost-effective, according to a new modeling study.” View full resource at medpagetoday.com
Most Recently Shared on July 27, 2011 at 5:20 pm By:
Health Gains May Not Justify Price of MS Drugs (CME/CE): (MedPage Today) -- Disease-modifying… http://goo.gl/fb/2oWah
Medical News: Health Gains May Not Justify Price of MS Drugs - in Clinical Context, Multiple Sclerosis from MedPage Today
medpagetoday.com — “Disease-modifying therapies (DMTs) in multiple sclerosis may offer clinical benefits, but they are far from being cost-effective, according to a new modeling study.” View full resource at medpagetoday.com
Most Recently Shared on July 27, 2011 at 4:20 pm By:
Health Gains May Not Justify Price of MS Drugs (CME/CE) http://bit.ly/pHZksr
MS Medications Cost 67% More In US Than Canada, UK, Germany
medicalnewstoday.com — “A category of medications commonly used to treat Multiple Sclerosis (MS), know as disease modifying drugs, cost Americans 67% more than fellow world leaders such as Britain, Canada, and Germany.” View full resource at medicalnewstoday.com
Most Recently Shared on July 22, 2011 at 12:57 am By:
MS Medications Cost 67% More In US Than Canada, UK, Germany: A category of medications commonly used to treat Mu... http://bit.ly/quIDLc
MS Medications Cost 67% More In US Than Canada, UK, Germany
medicalnewstoday.com — “A category of medications commonly used to treat Multiple Sclerosis (MS), know as disease modifying drugs, cost Americans 67% more than fellow world leaders such as Britain, Canada, and Germany.” View full resource at medicalnewstoday.com
Most Recently Shared on July 21, 2011 at 4:05 pm By:
MNT - Muscular Dys Health News
MS Medications Cost 67% More In US Than Canada, UK, Germany http://mnt.to/3Ys2 #musculardystrophy
Disease-Modifying Drugs For Multiple Sclerosis Not Cost-Effective At Present
medicalnewstoday.com — “A new study shows that the health gains associated with a category of medications commonly used to treat Multiple Sclerosis (MS) - know as disease modifying drugs- come at a very high cost when co” View full resource at medicalnewstoday.com
Most Recently Shared on July 21, 2011 at 8:05 am By:
Disease-Modifying Drugs For Multiple Sclerosis Not Cost-Effective At Present http://mnt.to/3YqX #multiplesclerosis
Health gains from multiple sclerosis drugs come at a high price, study finds
sciencedaily.com — “A new study shows that the health gains associated with a category of medications commonly used to treat multiple sclerosis (MS) -- know as disease modifying drugs -- come at a very high cost when compared to therapies that address the symptoms of MS and treatments for other chronic diseases.” View full resource at sciencedaily.com
Most Recently Shared on July 21, 2011 at 12:40 am By:
Health gains from multiple sclerosis drugs come at a high price, study finds: A new study shows that the health ... http://bit.ly/qhb4Pd
Health gains from multiple sclerosis drugs come at a high price, study finds
sciencedaily.com — “A new study shows that the health gains associated with a category of medications commonly used to treat multiple sclerosis (MS) -- know as disease modifying drugs -- come at a very high cost when compared to therapies that address the symptoms of MS and treatments for other chronic diseases.” View full resource at sciencedaily.com
Most Recently Shared on July 20, 2011 at 9:11 pm By:
Health gains from multiple sclerosis drugs come at a high price, study finds: A new study shows that the health gains .. http://dld.bz/ahxDJ
Study: MS Drugs Help, But Come at High Cost -- American Academy of Neurology
aan.com — “A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases. The research is published in the July 20, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology . Disease-modifying drugs for MS became available in the 1990s. While the” View full resource at aan.com
Most Recently Shared on July 20, 2011 at 8:36 pm By:
Neurology Journal Neurology and Medical Journal
Study: MS Drugs Help, But Come at High Cost, http://bit.ly/pmaNuq #neurology
Elan, Proteostasis create innovative drug discovery initiative for neurodegenerative disorders
news-medical.net — “Proteostasis Therapeutics and Elan Corporation today announced a strategic business relationship to advance Proteostasis' platform for the discovery and development of disease-modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders such as Parkinson's, Huntington's, multiple sclerosis and amyotrophic lateral sclerosis, and a broad array of dementia-related diseases including Alzheimer's.” View full resource at news-medical.net
Most Recently Shared on May 25, 2011 at 1:21 pm By:
Genetics News: Elan, Proteostasis create innovative drug discovery initiative for neurodegenerative disorders: P... http://bit.ly/kgg5Mh
In Multiple Sclerosis, Less Than Half Of Patients Continually Adhere To Drug Therapies For Treatment: Study
medicalnewstoday.com — “Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis (MS), and have been shown to reduce the frequency and severity of relapses. But according” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2011 at 9:05 am By:
MNT Drug Compliance Health News
In Multiple Sclerosis, Less Than Half Of Patients Continually Adhere To Drug Therapies For Treatment: Study http://mnt.to/3VGP
Advertisement
